UBS Group AG - REXAHN PHARMACEUTICALS INC ownership

REXAHN PHARMACEUTICALS INC's ticker is REXN and the CUSIP is 761640309. A total of 18 filers reported holding REXAHN PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of REXAHN PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2020$3,000
-57.1%
1,087
-71.4%
0.00%
Q1 2020$7,000
-41.7%
3,805
-40.0%
0.00%
Q4 2019$12,0000.0%6,340
+12.5%
0.00%
Q3 2019$12,000
+1100.0%
5,635
+3294.6%
0.00%
Q2 2019$1,0001660.00%
Other shareholders
REXAHN PHARMACEUTICALS INC shareholders Q4 2019
NameSharesValueWeighting ↓
Royal Fund Management, LLC 4$00.00%
American Portfolios Advisors 8$150.00%
Renaissance Technologies 148,333$283,0000.00%
ROYAL BANK OF CANADA 20$00.00%
VANGUARD GROUP INC 55,584$106,0000.00%
LADENBURG THALMANN FINANCIAL SERVICES INC. 49$00.00%
TCI Wealth Advisors, Inc. 8$00.00%
UBS Group AG 6,340$12,0000.00%
NEXT Financial Group, Inc 166$00.00%
Advisor Group, Inc. 23$00.00%
View complete list of REXAHN PHARMACEUTICALS INC shareholders